Jean-Martin Charcot (1825-1893)
Charcot ( fig 1) was born in 1825 in Paris and in 1853 qualified MD Paris. Virtually throughout his entire career he was associated with the great Paris hospital the Salpetriere, where he served from 1848 as interne and from 1862 as physician. He was at the Salpetriere when it was bombed in 1871 during the FrancoPrussian war. Initially, morbid anatomy was his ruling passion and the lung one of his special interests; his description of the pulmonary lobule remains a classic.1 2 In 1872 he became professor of pathological anatomy. At the same time, however, he pursued his clinical studies, especially in the field of nervous diseases, in which his contributions to the knowledge of such conditions as tabes dorsalis, multiple sclerosis, and hysteria were outstanding. In 1882 he was appointed to a chair in neurology, the first of its kind in the world. His lecture demonstrations at the Salpetriere were famous and attracted students from afar, including Sigmund Freud in 1885. Charcot died of acute pulmonary oedema secondary to aortic valvular disease in 1893. 3 It was early in his career at the Salpetriere that Charcot, with Charles-Philippe Robin (1821-1885), published in 1853 a report on the pathological findings in a case of leukaemia (leucocythe'mie) in which blood taken from the right ventricle and also the spleen showed microscopically the presence of crystals, which they also saw in the sputum of a woman with bronchitis. '4 Although aware that the crystals had been previously described by Charcot and others, he defended his claim for priority of discovery of the association of the crystals with asthma.
Early theories about Charcot-Leyden crystals After Charcot's description of the crystals in 1853, there was considerable speculation about their nature and possible role in asthma. Charcot himself did not appreciate the special significance of the crystals in asthma. Leyden's view was that the crystals developed from white blood corpuscles, seen in the blood and bone marrow. The presence of crystals in the sputum of asthmatic patients, however, led him to postu- 1890.26 Eosinophils in excess were detected also in the nasal mucosa and secretions of sufferers from hay fever. Moreover, in both asthma and hay fever the presence of Charcot-Leyden crystals was closely associated with that of eosinophils. The It is now generally accepted that Charcot-Leyden crystals are found wherever there is a large turnover of eosinophils, when they are present in excess, whether in blood, tissue, or secretions. Thus crystals are found in asthma not only in the sputum but also in specimens of bronchial mucosa removed at bronchoscopy, as well as in bronchial lavage washings. In hay fever, or allergic rhinitis, they may be present in the nasal secretions, in biopsy specimens of nasal mucosa, and in excised nasal polypi. They are present in the lung in tropical pulmonary eosinophilia (due to filaria) and pulmonary ascariasis. They are also seen in eosinophilic granuloma of bone. In intestinal disease, where there is eosinophilic infiltration of the mucosa (for example, in helminth infestations or food sensitivity reactions) the crystals may be detected in the stools. In leukaemia they may be present in the bone marrow, and it is a matter of speculation whether Charcot's original case in 1853 was one of myeloid leukaemia of the rare eosinophilic type. It has also been shown that Charcot-Leyden crystals may be found in relation to granular leucocytes of basophil type. 27 Charcot-Leyden crystals may be absent or difficult to find in a fresh specimen but appear after the specimen has stood awhile. There are now laboratory techniques whereby crystals may be readily formed in vitro by lysing the eosinophils, although this is possible only in primates-the eosinophils of guineapigs behave differently and do not produce crystals.
The chemical composition of the crystals has proved difficult to unravel. In 1856 Jean Baptiste Vidal (1825-1893)28 maintained that the crystals were haematoidin; in 1864 Nikolaus Friedreich (1825-1885)29 considered them to be tyrosine. The semen and tissue of the testis occasionally contain microscopic crystals known variously, by the names of their describers, as the crystals of Neumann, Reinke, or Lubarsch. These crystals are composed of spermine phosphate and it has been suggested that this is also the substance of which Charcot-Leyden crystals are formed. There is, however, no basis for this and the two varieties of crystal are quite distinct.
Recent research, however, has shown that CharcotLeyden crystals are composed of an acidic protein, of molecular weight about 13 000. 
